Company profile: Elitech
1.1 - Company Overview
Company description
- Provider of in vitro diagnostic equipment, reagents, and software for clinical and research laboratories, offering molecular diagnostics, clinical chemistry benchtop analyzers, microbiology solutions, and biomedical systems. Portfolio includes Selectra Mach5 and Selectra Pro & Mach5 systems with ready-to-use reagents, calibrators, controls, and consumables.
Products and services
- Clinical Chemistry: Delivers laboratory-grade benchtop analyzers and reagents for clinical chemistry labs, emphasizing ease of use, reliability, and analytical quality for routine testing workflows
- Molecular Diagnostics: Supplies modular instruments, reagents, and software for clinical and research laboratories, supporting molecular diagnostic workflows and compatible operations in these settings
- Selectra Pro & Mach5 systems: Produces integrated systems for clinical chemistry testing that include liquid stable ready-to-use reagents, calibrators, controls, and consumables for routine laboratory operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Elitech
Luminex
HQ: United States
Website
- Description: Provider of flow cytometry and imaging, supported by commercial, operations, research and development, and support personnel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminex company profile →
Immunostics
HQ: United States
Website
- Description: Provider of diagnostic solutions that assist in disease diagnosis, offering a compact automatic immunoassay analyzer, hemochroma PLUS hemoglobin/hematocrit device, hema-screen SPECIFIC GOLD colorectal cancer screening test, Swab-N-Go Home Test COVID-19 Ag with RAPIDCHECK app, Detector UA urine analysis strips, and Detector Strep A rapid test.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunostics company profile →
Roche
HQ: Switzerland
Website
- Description: Provider of pharmaceuticals and in-vitro diagnostics, including diagnostic tests and instruments for cancer, diabetes, and infectious diseases; develops medicines for oncology, neurology, virology, inflammation, metabolism, CNS, ophthalmology, immunology, and transplantation; offers digital health solutions for virtual care, decision support, and self-monitoring, plus diabetes management devices and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roche company profile →
MedDX
HQ: United Kingdom
Website
- Description: Provider of compliant packaging products and services for the healthcare sector, specializing in manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedDX company profile →
Oxford Biosystems
HQ: United Kingdom
Website
- Description: Provider of diagnostic and research reagents and instrumentation to laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Biosystems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Elitech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Elitech
2.2 - Growth funds investing in similar companies to Elitech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Elitech
4.2 - Public trading comparable groups for Elitech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →